Active	Status	Sponsor type	Region	Phase	Filter
1 Active 7 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
allogeneic K562-GM tumor cell vaccine / National Cancer Institute
NCT00487305: Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma	Completed	1	24	US	Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells	Dana-Farber Cancer Institute	Follicular Lymphoma	07/23	07/23